Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)

Market Cap	457.25B -38.7%
Revenue (ttm)	239.07B +6.2%
Net Income	-1.19B
EPS	-23.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	249
Open	13,100
Previous Close	13,100
Day's Range	12,800 - 13,100
52-Week Range	7,570 - 28,000
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About KRX:019175

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1962
• Employees: 656
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 019175

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error